Barnes & Noble Inc. (NYSE:BKS) Chairman Leonard Riggio, the bookseller’s founder and largest shareholder, cut his stake in the company to 20 percent by selling shares worth about $64 million. Barnes & Noble, Inc. (NYSE:BKS) shares after opening at $17.57 moved to $17.74 on last trade day and at the end of the day closed at $16.37. Company price to sales ratio in past twelve months was calculated as 0.16 and price to cash ratio as 2.04. Barnes & Noble, Inc. (NYSE:BKS) showed a negative weekly performance of -11.99%.
Inovio Pharmaceuticals Inc. (NYSEMKT:INO) has in the past couple of years been grabbing investor attention, with its innovative vaccines which adopt new bio-technology techniques to build preventive care drugs and vaccines. Inovio Pharmaceuticals Inc. (NYSEMKT:INO) shares fell -5.62% in last trading session and ended the day on $2.52. INO return on equity ratio is recorded as -144.40% and its return on assets is -92.70%. Inovio Pharmaceuticals Inc. (NYSEMKT:INO) yearly performance is 342.11%.
On Apr 17, zacks issued an updated research report on MoneyGram International Inc. (NASDAQ:MGI). The near-term outlook appears grim given the debt accretion amid higher restructuring costs, which may restrict margin growth. Nonetheless, higher cash flow, fair liquidity position and an optimistic guidance for 2014 remain impressive. Moneygram International Inc. (NASDAQ:MGI) shares moved down -17.68% in last trading session and was closed at $14.81, while trading in range of $14.19 – $15.99. Moneygram International Inc. (NASDAQ:MGI) year to date (YTD) performance is -28.73%.
Net 1 UEPS Technologies Inc. (NASDAQ:UEPS) dropped Thursday after The Constitutional Court of South Africa, the nation’s highest court, ordered the cancellation of a contract awarded to the electronic payment systems technology company. Net 1 UEPS Technologies Inc. (NASDAQ:UEPS) weekly performance is -7.37%. On last trading day company shares ended up $8.98. Net 1 UEPS Technologies Inc. (NASDAQ:UEPS) distance from 50-day simple moving average (SMA50) is -9.01%. Analysts mean target price for the company is $13.50.